$12.62
-0.12-0.94%
Last update: Oct 19, 4:11 PM
$12.63
-0.11-0.84%
The Chemours Co
CCNYSE
Chemours (CC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Chemours (CC) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided revenue in the range of $5.87B - $6.1B for the period.
Compared to prior guidance, Chemours maintained its revenue forecast from a prior range of $5.98B - $6.1B.
Chemours has issued 15 guidance updates between April 28, 2023 and August 4, 2026. During this period, the company raised its outlook 3 times and lowered it 8 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.42 | $-0.04 | $0.02 | $0.24 |
| Actual | $0.42 | $0.05 | $0.05 | $0.20 |
| Surprise | 0.00% | +225.0% | +150.0% | -16.7% |
| Revenue | ||||
| Estimate | $1.66B | $1.40B | $1.33B | $1.49B |
| Actual | $1.59B | $1.38B | $1.30B | $1.50B |
| Surprise | -4.13% | -1.30% | -2.18% | +0.01% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.26 | $0.17 | $0.39 | $0.66 |
| Revenue | ||||
| Consensus | $1.53B | $1.41B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $0.42 | $0.42 | 0.00 % |
| Q1 | May 5, 2026 | $0.05 | $-0.04 | 225.0 % |
| Q4 | Feb 19, 2026 | $0.05 | $0.02 | 150.0 % |
| Q3 | Nov 6, 2025 | $0.20 | $0.24 | -16.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $1.59B | $1.66B | -4.13 % |
| Q1 | May 5, 2026 | $1.38B | $1.40B | -1.30 % |
| Q4 | Feb 19, 2026 | $1.30B | $1.33B | -2.18 % |
| Q3 | Nov 6, 2025 | $1.50B | $1.49B | 0.01 % |
